Savara prices $4.20 offering for 23,809,524 common shares
Savara Inc. announced an underwritten offering, agreeing to issue and sell 23,809,524 shares of common stock at $4.20 per share and pre-funded warrants to purchase 7,142,857 shares with a $0.001 exercise price, priced at $4.199 per warrant.
Rhea-AI Filing Summary
Savara Inc. announced an underwritten offering, agreeing to issue and sell 23,809,524 shares of common stock at $4.20 per share and pre-funded warrants to purchase 7,142,857 shares with a $0.001 exercise price, priced at $4.199 per warrant. The company also granted the underwriters a 30‑day option to purchase up to an additional 4,642,857 shares at the public offering price, less underwriting discounts and commissions.
The transaction was conducted under Savara’s effective Form S-3 shelf, with closing expected on October 31, 2025, subject to customary conditions. Jefferies LLC and Piper Sandler & Co. acted as representatives of the several underwriters. Legal opinions related to the issuance were provided by Polsinelli PC.
Positive
- None.
Negative
- None.
Insights
Primary equity financing with pre-funded warrants; neutral impact.
Savara priced a firm-commitment deal comprising common shares at $4.20 and pre-funded warrants priced at $4.199 with a nominal $0.001 exercise price. The structure allows immediate capital from shares and near-equivalent cash from pre-funded warrants, which are typically used to accommodate ownership limits while aligning economics with common stock.
The underwriters received a 30-day option for up to 4,642,857 additional shares, which can increase gross proceeds if exercised. The offering uses the company’s effective Form S-3, and closing is expected on October 31, 2025, subject to customary conditions.
Key factors include actual allocation between shares and pre-funded warrants and whether the over-allotment option is exercised. Subsequent disclosures may detail net proceeds and intended uses.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Savara (SVRA) announce?
Is there an over-allotment option in the Savara (SVRA) offering?
When is the Savara (SVRA) offering expected to close?
Under what registration was the Savara (SVRA) offering made?
Who are the underwriters for Savara (SVRA)?
What are the prices and exercise terms of the pre-funded warrants?
AI-generated analysis. How Rhea-AI works. Not financial advice.